FORBES-TATE for CALIFORNIA LIFE SCIENCES ASSOCIATION
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH GREER | — |
Manufacturing MAN
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH GREER | — |
Medical/Disease Research/Clinical Labs MED
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH GREER | — |
Medicare/Medicaid MMM
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers; Issues related to transitional coverage of emerging technologies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH GREER | — |
Pharmacy PHA
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH GREER | — |
Taxation/Internal Revenue Code TAX
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH GREER | — |
Trade (domestic/foreign) TRD
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH GREER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.